Ara-290 10mg × 10 vials

ARA-290 10mg Peptide Benefits – Tissue Repair and Neuroprotective Research Overview

ARA-290 10mg peptide benefits are widely studied in laboratory and clinical research focused on nerve repair, inflammation control, tissue protection, and neuroimmune signaling pathways. ARA-290 (also known as cibinetide) is an 11–amino acid peptide derived from erythropoietin (EPO), engineered to activate the innate repair receptor (IRR) without stimulating red blood cell production.

The 10mg format is commonly used in research settings requiring higher total compound availability for dose-response studies, inflammatory pathway modeling, and repeated experimental cycles in neurobiology and tissue repair research.

What is ARA-290?

ARA-290 is a synthetic peptide developed from the helix B domain of erythropoietin. Unlike full EPO, it does not increase hematocrit. Instead, it selectively targets the innate repair receptor (EPOR/CD131 complex), which is activated during tissue injury and inflammation.

For product reference:

• ARA-290 10mg

ARA-290 10mg Peptide Benefits in Research

Neuroprotective and Nerve Repair Research

ARA-290 is widely studied for its ability to support nerve repair mechanisms. Research suggests it may influence:

• Peripheral nerve regeneration pathways
• Small fiber nerve repair models
• Reduced neuroinflammatory signaling

This makes it a key compound in studies involving neuropathic pain and nerve injury recovery models.

Anti-Inflammatory Signaling Benefits

One of the primary research benefits of ARA-290 is its modulation of inflammatory responses. It is used in studies examining:

• Reduction of pro-inflammatory cytokines
• Immune system signaling balance
• Macrophage activity modulation (M1 to M2 shift)

These effects are particularly relevant in chronic inflammation and autoimmune research models.

Microvascular and Endothelial Protection Research

ARA-290 is also studied for its role in protecting small blood vessels and improving microcirculation in damaged tissues. Research applications include:

• Endothelial function improvement studies
• Microvascular repair modeling
• Tissue oxygenation response analysis

Metabolic and Cellular Stress Response Benefits

In laboratory environments, ARA-290 is used to explore how cells respond to stress conditions such as hypoxia and oxidative damage. Research areas include:

• Cellular survival signaling pathways
• Oxidative stress reduction models
• Mitochondrial stress response interaction

Neuropathic Pain Pathway Research

ARA-290 is frequently included in experimental models of neuropathic pain, particularly:

• Diabetic neuropathy research
• Small fiber neuropathy studies
• Chronic pain signaling pathway analysis

It is investigated for its ability to modify pain signaling rather than simply blocking pain perception.

How ARA-290 Works

ARA-290 activates the innate repair receptor (IRR), a receptor complex expressed in injured or inflamed tissues. This activation triggers protective cellular pathways without affecting erythropoiesis.

Key Mechanisms in Research

• IRR activation (EPOR + CD131 complex)
• Anti-inflammatory cytokine regulation
• Neurotrophic and nerve repair signaling
• Cellular survival pathway activation (PI3K/Akt signaling)
• Reduced inflammatory nerve sensitization

This selective targeting is what separates ARA-290 from erythropoietin-based compounds.

Why Researchers Use ARA-290 10mg

The 10mg format is commonly selected for laboratory workflows that require:

• Multiple experimental runs per vial
• Consistent dosing in extended studies
• Comparative inflammation and nerve repair models
• High-concentration peptide availability

Product Specifications

• Compound: ARA-290 (Cibinetide)
• Strength: 10mg
• Form: Lyophilized powder
• Grade: Research use only
• Purity: High-purity laboratory standard with COA
• Use: Scientific and laboratory research only
• Storage: Refrigerate at 2–8°C
• Handling: Sterile laboratory procedures required

Research Applications of ARA-290 10mg

ARA-290 is commonly used in studies involving:

• Peripheral nerve regeneration
• Neuroinflammation reduction
• Chronic pain pathway modeling
• Immune system modulation
• Microvascular repair research
• Cellular stress response experiments
• Tissue protection and recovery studies

Benefits Summary (Research Context)

In laboratory studies, ARA-290 10mg is valued for its combined effects on:

• Nerve repair signaling pathways
• Inflammation regulation mechanisms
• Tissue protection under stress conditions
• Microvascular and endothelial support
• Neuroimmune communication research

Strong Internal Research Combinations

ARA-290 is often studied alongside:

• BPC-157 5mg – tissue repair and healing pathway research
• TB-500 5mg – cell migration and regeneration studies
• SS-31 10mg – mitochondrial protection research
• Cerebrolysin 60mg – neuroregeneration and brain signaling studies

Where to Buy ARA-290 10mg

Researchers looking for ARA-290 10mg peptide should source from verified suppliers offering:

• COA-backed quality assurance
• Sterile, research-grade manufacturing standards
• Batch consistency and traceability
• Wholesale and bulk supply options
• Secure international shipping

We provide ARA-290 10mg for laboratories, research institutions, and distributors conducting advanced neuroprotective and inflammation research.

• ARA-290 10mg

Frequently Asked Questions

What is ARA-290 10mg used for in research?

It is used in studies involving nerve repair, inflammation control, tissue protection, and neuroimmune signaling pathways.

Is ARA-290 the same as EPO?

No. ARA-290 is derived from EPO but does not stimulate red blood cell production.

Why is ARA-290 widely studied?

Because it selectively activates tissue repair pathways without affecting hematocrit levels.